Anti-Multi Ubiquitin mAb (Monoclonal Antibody)
Ubiquitin Monoclonal Antibody.


Specifications:
Description
Monoclonal antibody of 100 μg targeting Ubiquitin for WB.
Target: | Ubiquitin |
---|---|
Product Type: | Antibody |
Size: | 100 μg |
Application: | WB |
Research Area / Disease: | Cell Biology |
Conjugate: | Unlabeled |
Antibody Type: | Monoclonal |
Clone Number: | FK2 |
Concentration: | 1 mg/mL |
Formulation: | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained. |
Isotype: | IgG1 |
Immunogen: | Lysozyme - poly-ubiquitin was purified crude |
Host Species: | Mouse |
Species Reactivity: | Human |
Source: | This antibody was purified from hybridoma(clone FK2) supernatant using protein A agarose. Thishybridoma was established by fusion of mouse myelomacell with Balb/c mouse splenocyte immunized with a crudepoly-ubiquitin-lysozyme. |
Reactivity: | This antibody reacts with multiubiquitin chains, but it doesn’t react with mono ubiquitinand free ubiquitin on Western blotting. |
Storage Temperature: | -20°C |
Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
Citations
- Broering TJ et al. Carboxyl-proximal regions of reovirus nonstructural protein muNS necessary and sufficient for forming factory-like inclusions. J Virol. 79, 6194-6206 (2005),
- Choi UY et al. Polyubiquitin chain-dependent protein degradation in TRIM30 cytoplasmic bodies. Exp. Mol.Med. 47, e159 (2015),
- Ebina M et al. Myeloma overexpressed 2 (Myeov2) regulates L11 subnuclear localization through Nedd8 modification. PLoS One. 8, e65285 (2013),
- Furuya N et al. PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation. Autophagy 10, 631-41 (2014),
- Gitcho MA et al. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J Biol Chem. 284, 12384-98 (2009),
- Hosokawa H et al. Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3. J Immunol. 177, 7656-64 (2006),
- Hwang GW et al. Overexpression of Rad23 confers resistance to methylmercury in saccharomyces cerevisiae via inhibition of the degradation of ubiquitinated proteins. Mol Pharmacol. 68, 1074-8 (2005),
- Inukai N et al. A novel hydrogen peroxide-induced phosphorylation and ubiquitination pathway leading to RNA polymerase II proteolysis. J Biol Chem. 279, 8190-5 (2004),
- Ishioka T et al. Impairment of the ubiquitin-proteasome system by cellular FLIP. Genes Cells 12, 735-44 (2007),
- Katoh K et al. The ALG-2-interacting protein Alix associates with CHMP4b, a human homologue of yeast Snf7 that is involved in multivesicular body sorting. J Biol Chem. 278, 39104-13 (2003),
- Komatsu M et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131, 1149-1163 (2007),
- Masuda Y et al. ADRP/adipophilin is degraded through the proteasome-dependent pathway during regression of lipid-storing cells. J Lipid Res. 47, 87-98 (2006),
- Nakamura M et al. Clathrin anchors deubiquitinating enzymes, AMSH and AMSH-like protein, on early endosomes. Genes Cells 11, 593-606 (2006),
- Seino H et al. Two ubiquitin-conjugating enzymes, UbcP1/Ubc4 and UbcP4/Ubc11, have distinct functions for ubiquitination of mitotic cyclin. Mol Cell Biol. 23, 3497-3505 (2003),
- Shi W et al. Disassembly of MDC1 foci is controlled by ubiquitin-proteasome-dependent degradation. J Biol Chem. 283, 31608-16 (2008),
- Yamashita M et al. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J Biol Chem. 280, 29409-19 (2005)
- Matsumoto G et al. N-Acyldopamine induces aggresome formation without proteasome inhibition and enhances protein aggregation via p62/SQSTM1 expression. Sci Rep. 8, 9585 (2018)
- Jena KK et al. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62‐NRF2 axis and autophagy. EMBO J. 37, e98358 (2018)
- Chernyshova K et al. Glaucoma-Associated Mutations in the Optineurin Gene Have Limited Impact on Parkin-Dependent Mitophagy. Invest Ophthalmol Vis Sci. 60, 3625-3635 (2019)
References
- Ishioka, T., et al., Genes Cells 12, 735-744 (2007)
- Hosokawa, H., et al., J. Immunol. 177, 7656-7664 (2006)
- Masuda, Y., et al., J. Lipid Res. 47, 87-98 (2006)
- Nakamura, M., et al., Genes Cells 11, 593-606 (2006)
- Yamashita, M., et al., J. Biol. Chem. 280, 29409-29419 (2005)
- Hwang, G-W., et al., Mol. Pharmacol. 68, 1074-1078 (2005)
- Broering, T. J., et al., J. Virol. 79, 6194-6206 (2005)
- Inukai, N., et al., J. Biol. Chem. 279, 8190-8195 (2004)
- Katoh, K., et al., J. Biol. Chem. 278, 39104-39113 (2003)
- Seino, H., et al., Mol. Cell Biol. 23, 3497-3505 (2003)
- Yokosawa, N., et al., J. Virol. 76, 12683-12690 (2002)
- Takada, K., et al., Eur. J. Biochem. 233, 42-47 (1995)
- Fujimuro, M., et al., FEBS Lett. 349, 173-180 (1994)